Clinical Trial Update: L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating L-arginine for endothelium-dependent vasodilation and mitochondrial metabolism in MELAS syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melas Syndrome

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: MELAS Syndrome | Phase 2 | Status: COMPLETED